pamidronate has been researched along with Spinal Fractures in 34 studies
Spinal Fractures: Broken bones in the vertebral column.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study, we evaluated whether intravenous pamidronate can prevent bone loss and reduce vertebral fractures in patients with malignant lymphoma who were receiving chemotherapy." | 9.11 | Effect of pamidronate on new vertebral fractures and bone mineral density in patients with malignant lymphoma receiving chemotherapy. ( Hahn, JS; Kim, SH; Lim, SK, 2004) |
| "The effect of pamidronate therapy on bone histology was studied in patients with osteoporosis with at least one vertebral fracture in a randomized, double-masked, placebo-controlled, multi-center trial." | 9.09 | Bone histomorphometric evaluation of pamidronate treatment in clinically manifest osteoporosis. ( Bravenboer, N; Hamdy, NA; Holzmann, P; Lips, P; Netelenbos, JC; Papapoulos, SE, 1999) |
| "To determine the efficacy and safety of 21 monthly cycles of pamidronate therapy in patients with advanced multiple myeloma." | 9.08 | Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group. ( Ballester, O; Bell, R; Berenson, JR; Blacklock, H; Bordoni, R; Dimopoulos, MA; George, S; Heffernan, M; Keller, A; Knight, RD; Kovacs, M; Lichtenstein, A; Lipton, A; Porter, L; Reitsma, DJ; Seaman, J; Simeone, JF, 1998) |
| " Here, a case of a 9-year-old girl with familial HCS and multiple spinal fractures, who has been effectively treated with pamidronate, is presented." | 7.78 | Two-year cyclic infusion of pamidronate improves bone mass density and eliminates risk of fractures in a girl with osteoporosis due to Hajdu-Cheney syndrome. ( Galli-Tsinopoulou, A; Giannopoulou, EZ; Giza, S; Kyrgios, I; Laliotis, N; Maggana, I, 2012) |
| " To assess the role of biochemical bone markers in classification of children with osteogenesis imperfecta (OI), their possible association with vertebral compression fractures in milder forms of OI and their role in monitoring of intravenous pamidronate (APD) treatment." | 7.76 | Biochemical bone markers in the assessment and pamidronate treatment of children and adolescents with osteogenesis imperfecta. ( Aström, E; Eksborg, S; Magnusson, P; Söderhäll, S, 2010) |
| "To investigate the use of the aminobisphosphonate, disodium pamidronate, in children with vertebral osteoporosis." | 7.70 | Intravenous pamidronate in juvenile osteoporosis. ( Boivin, CM; Crabtree, NJ; Shaw, NJ, 2000) |
| "Pamidronate, a bisphosphonate analogue has been evaluated in a retrospective study for its analgesic effect on chronic back pain due to vertebral fractures in 26 patients suffering from senile osteoporosis or glucocorticoid-induced osteoporosis." | 7.70 | Analgesic effect of intravenous pamidronate on chronic back pain due to osteoporotic vertebral fractures. ( Appelboom, T; Gangji, V, 1999) |
| "We discuss this approach of treating osteoporosis with corticoids and immunosuppressors according to the present knowledge of bone biology." | 5.31 | [Vertebral osteoporosis induced by corticoids and cyclosporine ina a patient with Still disease]. ( Fassi, J; Plantalech, L, 2001) |
| "Our aim was to compare the analgesic efficacy of pamidronate (PAM) and synthetic human calcitonin (CT) in intravenous infusion for recent painful benign vertebral compression in a randomised prospective double-blind study." | 5.12 | Comparison of the analgesic efficacy of pamidronate and synthetic human calcitonin in osteoporotic vertebral fractures: a double-blind controlled study. ( Cantagrel, A; Cantogrel, S; Constantin, A; Jamard, B; Laroche, M; Mazières, B; Zabraniecki, L, 2006) |
| "We performed a randomized, double-blind, controlled clinical trial comparing intravenous pamidronate and placebo for pain relief in recent osteoporotic vertebral compression fractures (VCF)." | 5.12 | Intravenous pamidronate for pain relief in recent osteoporotic vertebral compression fracture: a randomized double-blind controlled study. ( Armingeat, T; Brondino, R; Lafforgue, P; Legré, V; Pham, T, 2006) |
| " In this study, we evaluated whether intravenous pamidronate can prevent bone loss and reduce vertebral fractures in patients with malignant lymphoma who were receiving chemotherapy." | 5.11 | Effect of pamidronate on new vertebral fractures and bone mineral density in patients with malignant lymphoma receiving chemotherapy. ( Hahn, JS; Kim, SH; Lim, SK, 2004) |
| "The effect of pamidronate therapy on bone histology was studied in patients with osteoporosis with at least one vertebral fracture in a randomized, double-masked, placebo-controlled, multi-center trial." | 5.09 | Bone histomorphometric evaluation of pamidronate treatment in clinically manifest osteoporosis. ( Bravenboer, N; Hamdy, NA; Holzmann, P; Lips, P; Netelenbos, JC; Papapoulos, SE, 1999) |
| "To determine the efficacy and safety of 21 monthly cycles of pamidronate therapy in patients with advanced multiple myeloma." | 5.08 | Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group. ( Ballester, O; Bell, R; Berenson, JR; Blacklock, H; Bordoni, R; Dimopoulos, MA; George, S; Heffernan, M; Keller, A; Knight, RD; Kovacs, M; Lichtenstein, A; Lipton, A; Porter, L; Reitsma, DJ; Seaman, J; Simeone, JF, 1998) |
| " Here, a case of a 9-year-old girl with familial HCS and multiple spinal fractures, who has been effectively treated with pamidronate, is presented." | 3.78 | Two-year cyclic infusion of pamidronate improves bone mass density and eliminates risk of fractures in a girl with osteoporosis due to Hajdu-Cheney syndrome. ( Galli-Tsinopoulou, A; Giannopoulou, EZ; Giza, S; Kyrgios, I; Laliotis, N; Maggana, I, 2012) |
| " To assess the role of biochemical bone markers in classification of children with osteogenesis imperfecta (OI), their possible association with vertebral compression fractures in milder forms of OI and their role in monitoring of intravenous pamidronate (APD) treatment." | 3.76 | Biochemical bone markers in the assessment and pamidronate treatment of children and adolescents with osteogenesis imperfecta. ( Aström, E; Eksborg, S; Magnusson, P; Söderhäll, S, 2010) |
| "Inhibition of skeletal mineralisation is a well-recognized complication of disodium etidronate therapy that was identified in the earliest studies of its use in osteoporosis and Paget's disease." | 3.70 | Gross vertebral collapse associated with long-term disodium etidronate treatment for pelvic Paget's disease. ( MacGowan, JR; Morris, VH; Pringle, J; Stamp, TC, 2000) |
| "To investigate the use of the aminobisphosphonate, disodium pamidronate, in children with vertebral osteoporosis." | 3.70 | Intravenous pamidronate in juvenile osteoporosis. ( Boivin, CM; Crabtree, NJ; Shaw, NJ, 2000) |
| "Pamidronate, a bisphosphonate analogue has been evaluated in a retrospective study for its analgesic effect on chronic back pain due to vertebral fractures in 26 patients suffering from senile osteoporosis or glucocorticoid-induced osteoporosis." | 3.70 | Analgesic effect of intravenous pamidronate on chronic back pain due to osteoporotic vertebral fractures. ( Appelboom, T; Gangji, V, 1999) |
| "Osteoporosis is a disorder of bone mineralisation occurring in about one third of adults with cystic fibrosis." | 3.01 | Bisphosphonates for osteoporosis in people with cystic fibrosis. ( Chang, AB; Conwell, LS; Jeffery, TC, 2023) |
| "Pamidronate treatment was associated with development of adynamic bone histology." | 2.71 | Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate. ( Bognar, I; Burris, L; Coco, M; Durkin, P; Faugere, MC; Figueroa, K; Glicklich, D; Greenstein, S; Malluche, H; McDonough, P; Schechner, R; Tellis, V; Wang, G, 2003) |
| "We discuss this approach of treating osteoporosis with corticoids and immunosuppressors according to the present knowledge of bone biology." | 1.31 | [Vertebral osteoporosis induced by corticoids and cyclosporine ina a patient with Still disease]. ( Fassi, J; Plantalech, L, 2001) |
| "Osteoporosis is common in patients with chronic cholestatic liver disease, and atraumatic spinal fracture is a recognized complication after orthotopic liver transplantation." | 1.30 | Intravenous bisphosphonate prevents symptomatic osteoporotic vertebral collapse in patients after liver transplantation. ( Day, CP; Francis, RM; Hudson, M; Manas, DM; Reeves, HL, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (23.53) | 18.2507 |
| 2000's | 19 (55.88) | 29.6817 |
| 2010's | 6 (17.65) | 24.3611 |
| 2020's | 1 (2.94) | 2.80 |
| Authors | Studies |
|---|---|
| Jeffery, TC | 1 |
| Chang, AB | 1 |
| Conwell, LS | 1 |
| Mhaskar, R | 1 |
| Kumar, A | 1 |
| Miladinovic, B | 1 |
| Djulbegovic, B | 1 |
| Wang, Z | 1 |
| Han, Z | 1 |
| Tao, J | 1 |
| Lu, P | 1 |
| Liu, X | 1 |
| Wang, J | 1 |
| Wu, B | 1 |
| Huang, Z | 1 |
| Yin, C | 1 |
| Tan, R | 1 |
| Gu, M | 1 |
| Singh, A | 1 |
| Schaeffer, EK | 1 |
| Reilly, CW | 1 |
| Aström, E | 1 |
| Magnusson, P | 1 |
| Eksborg, S | 1 |
| Söderhäll, S | 1 |
| Jenkinson, E | 1 |
| Galli-Tsinopoulou, A | 1 |
| Kyrgios, I | 1 |
| Giza, S | 1 |
| Giannopoulou, EZ | 1 |
| Maggana, I | 1 |
| Laliotis, N | 1 |
| Heijckmann, AC | 1 |
| Juttmann, JR | 1 |
| Wolffenbuttel, BH | 1 |
| Pappagallo, M | 1 |
| Breuer, B | 1 |
| Schneider, A | 1 |
| Sperber, K | 1 |
| Coco, M | 1 |
| Glicklich, D | 1 |
| Faugere, MC | 1 |
| Burris, L | 1 |
| Bognar, I | 1 |
| Durkin, P | 1 |
| Tellis, V | 1 |
| Greenstein, S | 1 |
| Schechner, R | 1 |
| Figueroa, K | 1 |
| McDonough, P | 1 |
| Wang, G | 1 |
| Malluche, H | 1 |
| Kim, SH | 1 |
| Lim, SK | 1 |
| Hahn, JS | 1 |
| Laroche, M | 2 |
| Cantogrel, S | 1 |
| Jamard, B | 1 |
| Constantin, A | 1 |
| Zabraniecki, L | 1 |
| Cantagrel, A | 1 |
| Mazières, B | 2 |
| Boot, AM | 1 |
| de Coo, RF | 1 |
| Pals, G | 1 |
| de Muinck Keizer-Schrama, SM | 1 |
| Armingeat, T | 1 |
| Brondino, R | 1 |
| Pham, T | 1 |
| Legré, V | 1 |
| Lafforgue, P | 1 |
| Bret, J | 1 |
| Brouchet, A | 1 |
| Lucarelli, S | 1 |
| Borrelli, O | 1 |
| Paganelli, M | 1 |
| Capocaccia, P | 1 |
| Frediani, T | 1 |
| Ferri, F | 1 |
| Cucchiara, S | 1 |
| Ward, KA | 1 |
| Adams, JE | 1 |
| Freemont, TJ | 1 |
| Mughal, MZ | 1 |
| Muschitz, C | 1 |
| Roschger, P | 1 |
| Patsch, J | 1 |
| Pollhammer, I | 1 |
| Koller, B | 1 |
| Klaushofer, K | 1 |
| Resch, H | 1 |
| Gleeson, H | 1 |
| Wiltshire, E | 1 |
| Briody, J | 1 |
| Hall, J | 1 |
| Chaitow, J | 1 |
| Sillence, D | 1 |
| Cowell, C | 1 |
| Munns, C | 1 |
| Reid, IR | 1 |
| Wattie, DJ | 1 |
| Evans, MC | 1 |
| Gamble, GD | 1 |
| Stapleton, JP | 1 |
| Cornish, J | 1 |
| Landman, JO | 1 |
| Hamdy, NA | 2 |
| Pauwels, EK | 1 |
| Papapoulos, SE | 3 |
| Berenson, JR | 1 |
| Lichtenstein, A | 1 |
| Porter, L | 1 |
| Dimopoulos, MA | 1 |
| Bordoni, R | 1 |
| George, S | 1 |
| Lipton, A | 1 |
| Keller, A | 1 |
| Ballester, O | 1 |
| Kovacs, M | 1 |
| Blacklock, H | 1 |
| Bell, R | 1 |
| Simeone, JF | 1 |
| Reitsma, DJ | 1 |
| Heffernan, M | 1 |
| Seaman, J | 1 |
| Knight, RD | 1 |
| Man, Z | 1 |
| Otero, AB | 1 |
| Seymour, JF | 1 |
| Reeves, HL | 1 |
| Francis, RM | 1 |
| Manas, DM | 1 |
| Hudson, M | 1 |
| Day, CP | 1 |
| Bravenboer, N | 1 |
| Holzmann, P | 1 |
| Netelenbos, JC | 1 |
| Lips, P | 1 |
| Abdulla, AJ | 1 |
| MacGowan, JR | 1 |
| Pringle, J | 1 |
| Morris, VH | 1 |
| Stamp, TC | 1 |
| Shaw, NJ | 1 |
| Boivin, CM | 1 |
| Crabtree, NJ | 1 |
| Gangji, V | 1 |
| Appelboom, T | 1 |
| Fassi, J | 1 |
| Plantalech, L | 1 |
| Geusens, P | 1 |
| Menten, J | 1 |
| Vosse, D | 1 |
| Vanhoof, J | 1 |
| van der Linden, S | 1 |
| Ninkovic, M | 1 |
| Love, S | 1 |
| Tom, BD | 1 |
| Bearcroft, PW | 1 |
| Alexander, GJ | 1 |
| Compston, JE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation[NCT02074631] | Phase 2 | 80 participants (Actual) | Interventional | 2015-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for pamidronate and Spinal Fractures
| Article | Year |
|---|---|
Bisphosphonates for osteoporosis in people with cystic fibrosis.
Topics: Adult; Alendronate; Bone Density Conservation Agents; Child; Cystic Fibrosis; Diphosphonates; Female | 2023 |
Bisphosphonates in multiple myeloma: an updated network meta-analysis.
Topics: Antineoplastic Agents; Bone Density Conservation Agents; Bone Diseases; Clodronic Acid; Diphosphonat | 2017 |
Clinical efficacy and safety of pamidronate therapy on bone mass density in early post-renal transplant period: a meta-analysis of randomized controlled trials.
Topics: Absorptiometry, Photon; Bone Density; Bone Density Conservation Agents; Diphosphonates; Humans; Immu | 2014 |
Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 1: do bisphosphonates relieve pain caused by acute osteoporotic vertebral compression fractures?
Topics: Administration, Oral; Aged; Back Pain; Bone Density Conservation Agents; Diphosphonates; Female; Fra | 2011 |
Bisphosphonates in the treatment of osteoporosis. Principles and efficacy.
Topics: Administration, Oral; Alendronate; Animals; Bone and Bones; Bone Density; Calcium Channel Blockers; | 2000 |
8 trials available for pamidronate and Spinal Fractures
| Article | Year |
|---|---|
Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate.
Topics: Adult; Anti-Inflammatory Agents; Biopsy; Bone Density; Diphosphonates; Female; Hormones; Humans; Imm | 2003 |
Effect of pamidronate on new vertebral fractures and bone mineral density in patients with malignant lymphoma receiving chemotherapy.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Bone Density; Diphosphonates; Female; Humans; Lymph | 2004 |
Comparison of the analgesic efficacy of pamidronate and synthetic human calcitonin in osteoporotic vertebral fractures: a double-blind controlled study.
Topics: Aged; Aged, 80 and over; Analgesics; Bone Density Conservation Agents; Calcitonin; Diphosphonates; F | 2006 |
Intravenous pamidronate for pain relief in recent osteoporotic vertebral compression fracture: a randomized double-blind controlled study.
Topics: Acute Disease; Aged; Aged, 80 and over; Analgesics; Back Pain; Bone Density Conservation Agents; Dip | 2006 |
Continuous therapy with pamidronate, a potent bisphosphonate, in postmenopausal osteoporosis.
Topics: Aged; Alkaline Phosphatase; Bone Density; Calcium; Diphosphonates; Double-Blind Method; Female; Huma | 1994 |
Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group.
Topics: Diphosphonates; Double-Blind Method; Drug Administration Schedule; Female; Fractures, Spontaneous; H | 1998 |
Bone histomorphometric evaluation of pamidronate treatment in clinically manifest osteoporosis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Bone and Bones; Bone Remodeling; Diphosphonates; Double-Blind | 1999 |
Lack of effect of intravenous pamidronate on fracture incidence and bone mineral density after orthotopic liver transplantation.
Topics: Adult; Anti-Inflammatory Agents; Bone Density; Diphosphonates; Female; Humans; Incidence; Injections | 2002 |
21 other studies available for pamidronate and Spinal Fractures
| Article | Year |
|---|---|
Vertebral Fractures in Duchenne Muscular Dystrophy Patients Managed With Deflazacort.
Topics: Adolescent; Adrenal Cortex Hormones; Bone Density; Bone Density Conservation Agents; Child; Diphosph | 2018 |
Biochemical bone markers in the assessment and pamidronate treatment of children and adolescents with osteogenesis imperfecta.
Topics: Adolescent; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone Density; Bone Density Conservation A | 2010 |
Two-year cyclic infusion of pamidronate improves bone mass density and eliminates risk of fractures in a girl with osteoporosis due to Hajdu-Cheney syndrome.
Topics: Abnormalities, Multiple; Acro-Osteolysis; Bone Density; Bone Density Conservation Agents; Child; Dip | 2012 |
Intravenous pamidronate compared with oral alendronate for the treatment of postmenopausal osteoporosis.
Topics: Administration, Oral; Aged; Alendronate; Bone Density; Diphosphonates; Female; Fractures, Spontaneou | 2002 |
Treatment of chronic mechanical spinal pain with intravenous pamidronate: a review of medical records.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Back Pain; Chronic Disease; Diphosphonates | 2003 |
Muscle weakness as presenting symptom of osteogenesis imperfecta.
Topics: Bone Density Conservation Agents; Child, Preschool; Diphosphonates; Electromyography; Electrophoresi | 2006 |
Clinical and densitometric efficacy of the association of interferon alpha and pamidronate in the treatment of osteoporosis in patients with systemic mastocytosis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Bone Density; Bone Marrow Cells; Bone Remodeling; Diphosphona | 2007 |
Vertebral fractures and increased sensitivity to corticosteroids in a child with ulcerative colitis: successful use of pamidronate.
Topics: Back Pain; Bone Density; Bone Density Conservation Agents; Child; Colitis, Ulcerative; Diphosphonate | 2006 |
Can bisphosphonate treatment be stopped in a growing child with skeletal fragility?
Topics: Accidental Falls; Bone Density; Bone Density Conservation Agents; Child, Preschool; Diphosphonates; | 2007 |
High-dose bisphosphonate therapy in an urgent case of spontaneous multiple vertebral fractures in a 55 year old woman.
Topics: Absorptiometry, Photon; Accidental Falls; Administration, Oral; Biopsy; Bone and Bones; Bone Density | 2007 |
Childhood chronic recurrent multifocal osteomyelitis: pamidronate therapy decreases pain and improves vertebral shape.
Topics: Adolescent; Anti-Inflammatory Agents; Bone Density; Child; Child, Preschool; Diphosphonates; Female; | 2008 |
Skeletal metabolism in patients with osteoporosis after discontinuation of long-term treatment with oral pamidronate.
Topics: Administration, Oral; Bone and Bones; Bone Density; Diphosphonates; Female; Femur Neck; Follow-Up St | 1995 |
[New spine and non-spine fractures in 871 women/year treated with oral pamidronate plus calcium and vitamin D supplements].
Topics: Accidental Falls; Bone Density; Calcium, Dietary; Diphosphonates; Female; Follow-Up Studies; Fractur | 1997 |
Long-term pamidronate in multiple myeloma.
Topics: Antineoplastic Agents; Diphosphonates; Female; Fractures, Spontaneous; Humans; Male; Multiple Myelom | 1998 |
Intravenous bisphosphonate prevents symptomatic osteoporotic vertebral collapse in patients after liver transplantation.
Topics: Absorptiometry, Photon; Adult; Aged; Bone Density; Diphosphonates; Female; Follow-Up Studies; Fractu | 1998 |
Use of pamidronate for acute pain relief following osteoporotic vertebral fractures.
Topics: Acute Disease; Aged; Aged, 80 and over; Analgesics; Diphosphonates; Female; Humans; Middle Aged; Ost | 2000 |
Gross vertebral collapse associated with long-term disodium etidronate treatment for pelvic Paget's disease.
Topics: Aged; Alkaline Phosphatase; Anti-Inflammatory Agents; Arthralgia; Diphosphonates; Etidronic Acid; Fo | 2000 |
Intravenous pamidronate in juvenile osteoporosis.
Topics: Absorptiometry, Photon; Acute-Phase Reaction; Adolescent; Bone Density; Child; Diphosphonates; Femal | 2000 |
Analgesic effect of intravenous pamidronate on chronic back pain due to osteoporotic vertebral fractures.
Topics: Activities of Daily Living; Aged; Anti-Inflammatory Agents; Back Pain; Diphosphonates; Female; Human | 1999 |
[Vertebral osteoporosis induced by corticoids and cyclosporine ina a patient with Still disease].
Topics: Adrenal Cortex Hormones; Adult; Benzothiadiazines; Calcitonin; Cyclosporine; Diphosphonates; Diureti | 2001 |
Recovery from severe glucocorticoid-induced osteoporosis in an adolescent boy.
Topics: Adolescent; Anti-Inflammatory Agents; Body Height; Bone Density; Brain Stem Neoplasms; Diphosphonate | 2001 |